Skip to content

MYRIAD GENETICS INC

MYGN

CIK 0000899923

← back to feed
Revenue (TTM)
$815.1M
−1.6% YoY Q1 May 2026
Net Income (TTM)
−$392.1M
−187.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$4.22
−180.1% YoY Q1 May 2026
Gross Margin
69.6%
Q1 May 2026
Operating Margin
-50.6%
Q1 May 2026
Net Margin
-48.1%
Q1 May 2026
Free Cash Flow (TTM)
−$122.2M
Q1 May 2026
Cash
$124.4M
Q1 May 2026
Total Debt
$320.3M
Q1 May 2026
Shares Outstanding
94.45M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings